Sustained Lung Inflation With CPAP in Preterm Neonates (SI-CPAP)
SI-CPAP
Effect of Sustained Lung Inflation During CPAP in Preterm Neonates With Respiratory Distress Syndrome
1 other identifier
interventional
100
0 countries
N/A
Brief Summary
Neonatal respiratory distress syndrome (RDS) is the most common cause of respiratory failure in the first few days in life. It is characterized by the tendency of alveoli and terminal bronchioles to collapse due to the lack of surfactant. RDS is inversely related to gestational age and remains a dominant clinical problem encountered among preterm infants. The reduction in tidal volume secondary to alveolar collapse may result in alveolar derecruitment, cyclic opening and closing of atelectatic alveoli and distal small airways leading to inflammation and lung injury). On the other hand, the use of high positive end expiratory pressure (PEEP) may be associated with excessive lung parenchyma strain and unfavorable hemodynamic effects. Therefore, lung recruitment maneuvers have been proposed and used to open collapsed lung while managing with low pressure PEEP. However, the best recruitment maneuver technique is currently unknown. Proinflammatory cytokines are synthesized by alveolar macrophages, type II pneumocytes and other local pulmonary cells causing inflammation that starts a cascade leading to lung injury. Nevertheless, they are released systemically and can lead to injury of other organs. This study aims to measure inflammatory cytokines in the serum of premature infants who receive and do not receive sustained lung inflation. The study hypothesis is that, in premature infants supported with CPAP, the use of sustained inflation is associated with decreased inflammatory biomarkers and improved respiratory outcomes. The study includes infants with gestational age of 28-24 weeks during the first 6 hours of life who will be randomly assigned to either receive (or do not receive) sustained inflations. Serum concentrations of cytokines (IL-6, IL-8, IL-1β and TNF-α) will be measured at enrollment and at 96 hours. The primary outcome of this study will be the change in serum cytokine concentrations after intervention in both groups. Clinical respiratory outcomes will be monitored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2013
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 15, 2016
CompletedFirst Submitted
Initial submission to the registry
April 13, 2019
CompletedFirst Posted
Study publicly available on registry
April 16, 2019
CompletedApril 18, 2019
April 1, 2019
3.2 years
April 13, 2019
April 17, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Serum concentration of cytokines
IL-6, IL-8, IL-1β, - TNF-α and elastase will be measured in all subjects in group, group B, and group C.
At 96 hours of life
Secondary Outcomes (1)
Oxygen requirement
At 96 hours of life
Study Arms (3)
Group A
EXPERIMENTALInfants in the group receive CPAP for respiratory support in the delivery room. In addition, they receive a total of 15 sustained lung inflations in the first 96 hours of life; 6 in the first day, 3 in the second day, 3 in the third day and 3 in the forth day of life.
Group B
EXPERIMENTALInfants in the group receive CPAP for respiratory support in the delivery room. No sustained lung inflation will be applied.
Group C
ACTIVE COMPARATORInfants in this group are intubated in the delivery room and supported with mechanical ventilation.
Interventions
Preterm infants will receive a total of 15 sustained lung inflations during the first 4 days of life as follows: 1. On day 1 of life (a total of 6 sustained lung inflations, 20 cmH2O for 21 seconds each) once at enrollment and then once every 4 hours 2. On day 2 of life (a total of 3 sustained lung inflations, 15 cmH2O for 21 seconds each) once every 8 hours. 3. On day 3 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours. 4. On day 4 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.
Preterm infants will receive CPAP for respiratory support.
Preterm infants in this group will receive mechanical ventilation for respiratory support
Eligibility Criteria
You may qualify if:
- Gestational age between 28 weeks (and 0 days) and 34 weeks (and 6 days)
- Postnatal age \<6 hours
- Respiratory distress syndrome diagnosed by both clinical findings of subcostal retractions, tachypnea (\>70 breaths/min), the need for respiratory support to maintain oxygen saturation \> 87% and X-ray findings of RDS
- Application of early CPAP \<6 hours of age
- Oxygen requirement (FiO2 \>30% to maintain preductal saturation 87% - 93%)
You may not qualify if:
- Before enrollment: infants will not be considered in the study if any of the following conditions exists: major congenital anomalies, severe hemodynamic instability indicative of early septicemia, use of inotropes, severe metabolic acidemia with base deficit \>12 mEq/dl, frequent apnea / bradycardia (6 episodes per day with HR \<100 or 2 episodes per day with HR\<60 requiring bag-and-mask ventilation), maternal chorioamnionitis (fever \>38 degree Celsius with abdominal tenderness) and PPROM \>18 hours, and perinatal hypoxia (Apgar score \< 6 at 5 minutes)
- After enrollment: infants will be eliminated from the study if the initial blood culture on admission is positive.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Abdel-Hady H, Shouman B, Aly H. Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev. 2011 Mar;87(3):205-8. doi: 10.1016/j.earlhumdev.2010.12.010. Epub 2011 Jan 26.
PMID: 21276671BACKGROUNDAly H. Ventilation without tracheal intubation. Pediatrics. 2009 Aug;124(2):786-9. doi: 10.1542/peds.2009-0256. Epub 2009 Jul 27. No abstract available.
PMID: 19651592BACKGROUNDAttar MA, Donn SM. Mechanisms of ventilator-induced lung injury in premature infants. Semin Neonatol. 2002 Oct;7(5):353-60. doi: 10.1053/siny.2002.0129.
PMID: 12464497BACKGROUNDLista G, Fontana P, Castoldi F, Cavigioli F, Dani C. Does sustained lung inflation at birth improve outcome of preterm infants at risk for respiratory distress syndrome? Neonatology. 2011;99(1):45-50. doi: 10.1159/000298312. Epub 2010 Jul 9.
PMID: 20616570BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- All laboratory testing will be performed by investigators who are not aware of group assignment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Pediatrics
Study Record Dates
First Submitted
April 13, 2019
First Posted
April 16, 2019
Study Start
January 1, 2013
Primary Completion
March 15, 2016
Study Completion
March 15, 2016
Last Updated
April 18, 2019
Record last verified: 2019-04
Data Sharing
- IPD Sharing
- Will not share